[go: up one dir, main page]

AU1810899A - Neuropilins and use thereof in methods for diagnosis and prognosis of cancer - Google Patents

Neuropilins and use thereof in methods for diagnosis and prognosis of cancer

Info

Publication number
AU1810899A
AU1810899A AU18108/99A AU1810899A AU1810899A AU 1810899 A AU1810899 A AU 1810899A AU 18108/99 A AU18108/99 A AU 18108/99A AU 1810899 A AU1810899 A AU 1810899A AU 1810899 A AU1810899 A AU 1810899A
Authority
AU
Australia
Prior art keywords
neuropilins
prognosis
diagnosis
cancer
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18108/99A
Inventor
Michael Klagsbrun
Hua-Quan Miao
Shay Soker
Seiji Takashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Childrens Hospital
Original Assignee
Boston Childrens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Childrens Hospital filed Critical Boston Childrens Hospital
Publication of AU1810899A publication Critical patent/AU1810899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU18108/99A 1997-12-09 1998-12-09 Neuropilins and use thereof in methods for diagnosis and prognosis of cancer Abandoned AU1810899A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6915597P 1997-12-09 1997-12-09
US60069155 1997-12-09
US6968797P 1997-12-12 1997-12-12
US60069687 1997-12-12
PCT/US1998/026127 WO1999030157A2 (en) 1997-12-09 1998-12-09 Neuropilins in methods for diagnosis and prognosis of cancer

Publications (1)

Publication Number Publication Date
AU1810899A true AU1810899A (en) 1999-06-28

Family

ID=26749747

Family Applications (2)

Application Number Title Priority Date Filing Date
AU18108/99A Abandoned AU1810899A (en) 1997-12-09 1998-12-09 Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
AU19060/99A Abandoned AU1906099A (en) 1997-12-09 1998-12-09 Peptide antagonists of vascular endothelial growth factor

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU19060/99A Abandoned AU1906099A (en) 1997-12-09 1998-12-09 Peptide antagonists of vascular endothelial growth factor

Country Status (5)

Country Link
EP (1) EP1037994A1 (en)
JP (2) JP4312955B2 (en)
AU (2) AU1810899A (en)
CA (1) CA2313390A1 (en)
WO (2) WO1999030157A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7423125B2 (en) 1995-08-01 2008-09-09 Vegenics Limited Antibodies to VEGF-C
US6635421B1 (en) * 1997-12-09 2003-10-21 Children's Medical Center Corporation Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
WO2001052875A1 (en) * 2000-01-18 2001-07-26 Ludwig Institute For Cancer Research Vegf-d/vegf-c/vegf peptidomimetic inhibitor
WO2001062942A2 (en) 2000-02-25 2001-08-30 Ludwig Institute For Cancer Research MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS
US8263739B2 (en) 2000-06-02 2012-09-11 Bracco Suisse Sa Compounds for targeting endothelial cells, compositions containing the same and methods for their use
EP2286843A3 (en) 2000-06-02 2011-08-03 Bracco Suisse SA Compounds for targeting endothelial cells
JP2004508048A (en) * 2000-09-05 2004-03-18 カロリンスカ　イノベーションズ　アクティーエボラーグ Materials and Methods for Endothelial Cell Growth Inhibitors
GB0029015D0 (en) 2000-11-28 2001-01-10 Univ London Medical device
US7611711B2 (en) 2001-01-17 2009-11-03 Vegenics Limited VEGFR-3 inhibitor materials and methods
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
WO2004065621A1 (en) 2002-03-01 2004-08-05 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
GB0207644D0 (en) * 2002-04-02 2002-05-15 Ark Therapeutics Ltd Peptides and their use
EP2284180B1 (en) 2003-03-03 2015-09-09 Dyax Corp. Uses of peptides that specifically bind HGF receptor (cMET)
JP2009504679A (en) * 2005-08-12 2009-02-05 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Methods of treating diseases using VEGF antagonists
DE602006020881D1 (en) 2005-08-15 2011-05-05 Vegenics Pty Ltd ENEN FEATURES
BRPI0617488A2 (en) * 2005-10-21 2011-07-26 Bayer Healthcare Llc Method for monitoring the condition of a disease associated with a vegf-165 pathway activated by ultra-expression or vegf-165 protein mutation in one patient, Therapy selection method for a human patient with a dignified disease and method to detect disease associated with an ultra-expression-activated vegf-165 pathway or vegf-165 protein mutation in a patient
UA96139C2 (en) 2005-11-08 2011-10-10 Дженентек, Інк. Anti-neuropilin-1 (nrp1) antibody
BR112012017071A2 (en) * 2010-01-14 2016-04-12 Univ Nagoya City pharmaceutical product to prevent or treat disorders accompanied by ocular agiogenesis and / or increased ocular vascular permeability
CN103097418A (en) 2010-07-09 2013-05-08 霍夫曼-拉罗奇有限公司 Anti-neuropilin antibodies and methods of use
CN113226367B (en) 2018-04-06 2025-05-06 Atyr医药公司 Compositions and methods comprising anti-NRP2 antibodies
JP7701913B2 (en) 2019-10-03 2025-07-02 エータイアー ファーマ， インコーポレイテッド Compositions and methods involving anti-NRP2 antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1173991C (en) * 1992-11-13 2004-11-03 马克斯普朗克科学促进协会 F1K-1 as vascular endothelial growth factor receptor
US6020473A (en) * 1995-08-25 2000-02-01 Genentech, Inc. Nucleic acids encoding variants of vascular endothelial cell growth factor

Also Published As

Publication number Publication date
WO1999029861A1 (en) 1999-06-17
AU1906099A (en) 1999-06-28
WO1999030157A9 (en) 1999-10-21
WO1999030157A3 (en) 1999-07-22
JP2001526032A (en) 2001-12-18
JP4312955B2 (en) 2009-08-12
JP2009148293A (en) 2009-07-09
EP1037994A1 (en) 2000-09-27
CA2313390A1 (en) 1999-06-17
WO1999030157A2 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
AU1810899A (en) Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
AU1931899A (en) Optoacoustic contrast agents and methods for their use
AU2010699A (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse
AU6492798A (en) Microscope slide system and method of use
AU1807300A (en) Detection of loss of heterozygosity in tumor and serum of melanoma patients
AU5155398A (en) Anti-ccr5 antibodies and methods of use therefor
AU6148898A (en) 2-substituted 7-haloindenes and methods for synthesizing
AU2160297A (en) Method for the production of activated marked tumor-specific t cells and use thereof in treatment of tumors
AU3182999A (en) Methods of diagnosis and triage using cell activation measures
EP1144632A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU1465801A (en) Methods for cancer prognosis and diagnosis
AU2582195A (en) Method of detecting cancer involving fragments of cytokeratin 18 and corresponding antibodies
AU1132595A (en) Chromosome 18q loss and prognosis in colorectal cancer
AU5543494A (en) Method and kit for cancer diagnosis
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU4003597A (en) Methods of diagnosing and treating cancer
EP0965840A4 (en) Method for analyzing annexin v in urine and use thereof
AU9301998A (en) Composition and methods using galectin-1
AU4150999A (en) Method and kit for early diagnosis of cancer
EP0794174A3 (en) Labeled reagents for use in immunoassays and fluorescent compounds and complexes used therein
AU1763097A (en) Detection of prostate-specific antigen in breast tumors and serum
AU9018598A (en) Prognostic compositions for prostate cancer and methods of use thereof
AU6653698A (en) Use of the p-ten suppressor gene in diagnosis and treatment of cancer
AU9061098A (en) Method and test kit for detecting malignant tumours
AU8492598A (en) Methods and compositions for tumor reduction

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase